Compare · NXL vs PRKS
NXL vs PRKS
Side-by-side comparison of Nexalin Technology Inc. (NXL) and United Parks & Resorts Inc. (PRKS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NXL and PRKS operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- PRKS is the larger of the two at $2.16B, about 205.2x NXL ($10.5M).
- Over the past year, NXL is down 60.2% and PRKS is down 7.4% - PRKS leads by 52.8 points.
- PRKS has been more active in the news (11 items in the past 4 weeks vs 2 for NXL).
- PRKS has more recent analyst coverage (8 ratings vs 0 for NXL).
PerformanceNXL-60.21%PRKS-7.39%
2025-07-21+0.00%2026-07-17
- Company
- Nexalin Technology Inc.
- United Parks & Resorts Inc.
- Price
- $0.48+6.58%
- $45.04-4.17%
- Market cap
- $10.5M
- $2.16B
- 1M return
- +21.63%
- -2.01%
- 1Y return
- -60.21%
- -7.39%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- 2013
- News (4w)
- 2
- 11
- Recent ratings
- 0
- 8
Latest NXL
- SEC Form DEF 14A filed by Nexalin Technology Inc.
- SEC Form PRE 14A filed by Nexalin Technology Inc.
- Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
- Nexalin Technology Inc. filed SEC Form 8-K: Financial Statements and Exhibits
- Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life
- Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
- Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
- Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury
- Nexalin Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
Latest PRKS
- UNITED PARKS & RESORTS INC. ANNOUNCES SECOND QUARTER 2026 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION
- Northcoast initiated coverage on United Parks & Resorts Inc.
- Large owner Hill Path Capital Partners Co-Investment S Lp was granted 1,821 shares (SEC Form 4)
- Large owner Hill Path Capital Partners Lp was granted 1,821 shares (SEC Form 4)
- Director Chambers James P. was granted 1,098 shares, increasing direct ownership by 2% to 65,558 units (SEC Form 4)
- Director Gray William was granted 1,258 shares, increasing direct ownership by 2% to 76,721 units (SEC Form 4)
- Director Hartnett Timothy was granted 1,821 shares, increasing direct ownership by 2% to 81,378 units (SEC Form 4)
- Director Lipman Nathaniel was granted 207 shares, increasing direct ownership by 1% to 20,316 units (SEC Form 4)
- Director Schaefer Kimberly was granted 415 shares, increasing direct ownership by 0.98% to 42,740 units (SEC Form 4)
- Director Narang Neha Jogani was granted 830 shares, increasing direct ownership by 1% to 57,376 units (SEC Form 4)